Position in LQDA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$76,452,458
+$45,807,956 QoQ
Shares Held
958,892
+18.1% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#16
of 334 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LQDA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. LQDA ranks #10 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,199,799 | $229,937,554 | |
| 2 | VTRS |
Viatris Inc
|
13,564,872 | $215,410,166 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,129,240 | $207,658,650 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
5,173,865 | $179,377,897 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
631,892 | $106,499,075 | |
| 6 | ALKS |
Alkermes plc.
|
2,023,984 | $106,056,760 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
814,096 | $90,315,809 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
165,979 | $89,932,399 |
All Filings in LQDA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $76,452,458 | 958,892 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $30,644,502 | 811,990 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $24,284,305 | 704,097 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $63,269,160 | 2,782,285 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $30,115,881 | 2,417,005 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $12,703,157 | 861,231 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $9,152,524 | 778,276 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,604,670 | 260,467 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,998,840 | 166,570 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,900,799 | 264,461 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,201,242 | 432,356 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $750,535 | 118,381 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,101,417 | 140,308 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $1,148,994 | 166,280 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $1,275,961 | 200,308 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $1,733,183 | 318,600 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $246,317 | 56,495 | Shares | Defined | 2022-08-18 | |
| 2022-03-31 | $832,836 | 115,994 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $88,828 | 18,240 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $43,285 | 15,683 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $209,797 | 73,356 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $136,743 | 50,834 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||